s-adenosylmethionine has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, A; Brantley, MA; Haines, JL; Jones, DP; Ma, C; Mitchell, SL; Pericak-Vance, MA; Scott, WK; Uppal, K | 1 |
| Erdoğan, A; Gültekin, M; Gümüşlü, S; Sahin, E; Sahin, M | 2 |
| Chen, G; Pakneshan, P; Rabbani, SA; Shukeir, N; Szyf, M | 1 |
1 review(s) available for s-adenosylmethionine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability.
Topics: Animals; DNA Methylation; DNA Modification Methylases; Gene Expression Regulation, Neoplastic; Genomic Instability; Histones; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; S-Adenosylmethionine | 2010 |
3 other study(ies) available for s-adenosylmethionine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients.
Topics: Aged; Carnitine; Case-Control Studies; Discriminant Analysis; Female; Humans; Least-Squares Analysis; Linear Models; Lipids; Macular Degeneration; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Middle Aged; Neovascularization, Pathologic | 2021 |
Inhibition of angiogenesis by S-adenosylmethionine.
Topics: Angiogenesis Inhibitors; Capillaries; Cell Movement; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Humans; Neovascularization, Pathologic; Neovascularization, Physiologic; S-Adenosylmethionine | 2011 |
Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Methylation; DNA-Binding Proteins; Down-Regulation; Genetic Therapy; Humans; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neovascularization, Pathologic; Oligonucleotides, Antisense; Plasminogen Activators; Prostatic Neoplasms; RNA, Messenger; S-Adenosylmethionine; Transfection; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2006 |